- Home
- FBP vs KYMR Comparison
FBP vs KYMR Comparison
Compare FBP & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBP
- KYMR
- Stock Information
- Founded
- FBP 1948
- KYMR 2015
- Country
- FBP United States
- KYMR United States
- Employees
- FBP N/A
- KYMR N/A
- Industry
- FBP Major Banks
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- FBP Finance
- KYMR Health Care
- Exchange
- FBP Nasdaq
- KYMR Nasdaq
- Market Cap
- FBP 3.3B
- KYMR 2.7B
- IPO Year
- FBP N/A
- KYMR 2020
- Fundamental
- Price
- FBP $19.39
- KYMR $36.81
- Analyst Decision
- FBP Buy
- KYMR Buy
- Analyst Count
- FBP 4
- KYMR 15
- Target Price
- FBP $22.00
- KYMR $55.27
- AVG Volume (30 Days)
- FBP 889.9K
- KYMR 466.1K
- Earning Date
- FBP 01-23-2025
- KYMR 02-27-2025
- Dividend Yield
- FBP 3.71%
- KYMR N/A
- EPS Growth
- FBP 5.85
- KYMR N/A
- EPS
- FBP 1.81
- KYMR N/A
- Revenue
- FBP $878,280,000.00
- KYMR $87,563,000.00
- Revenue This Year
- FBP N/A
- KYMR N/A
- Revenue Next Year
- FBP $6.97
- KYMR $32.89
- P/E Ratio
- FBP $10.72
- KYMR N/A
- Revenue Growth
- FBP 1.74
- KYMR 86.92
- 52 Week Low
- FBP $16.24
- KYMR $29.24
- 52 Week High
- FBP $22.40
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- FBP 39.38
- KYMR 42.51
- Support Level
- FBP $20.23
- KYMR $36.67
- Resistance Level
- FBP $20.73
- KYMR $38.24
- Average True Range (ATR)
- FBP 0.47
- KYMR 1.78
- MACD
- FBP -0.16
- KYMR 0.06
- Stochastic Oscillator
- FBP 3.93
- KYMR 51.81
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.